Teleflex (TFX) Projected to Post Earnings on Thursday

Teleflex (NYSE:TFX - Get Free Report) is projected to announce its Q2 2025 earnings results before the market opens on Thursday, July 31st. Analysts expect the company to announce earnings of $3.36 per share and revenue of $771.53 million for the quarter. Teleflex has set its FY 2025 guidance at 13.200-13.600 EPS.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. During the same period in the prior year, the company earned $3.21 EPS. Teleflex's revenue for the quarter was down 5.0% on a year-over-year basis. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Price Performance

TFX traded up $1.05 on Friday, reaching $117.25. The stock had a trading volume of 326,403 shares, compared to its average volume of 581,484. Teleflex has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The firm has a 50-day moving average of $119.49 and a 200-day moving average of $139.02. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $5.18 billion, a price-to-earnings ratio of 36.99, a price-to-earnings-growth ratio of 1.84 and a beta of 1.08.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.16%. Teleflex's payout ratio is presently 42.90%.

Institutional Investors Weigh In On Teleflex

A hedge fund recently raised its stake in Teleflex stock. Empowered Funds LLC increased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 15.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,684 shares of the medical technology company's stock after purchasing an additional 230 shares during the period. Empowered Funds LLC's holdings in Teleflex were worth $233,000 at the end of the most recent quarter. Institutional investors own 95.62% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Wells Fargo & Company lowered their target price on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, May 2nd. Royal Bank Of Canada set a $130.00 price target on Teleflex and gave the company a "sector perform" rating in a research note on Tuesday, July 15th. Morgan Stanley decreased their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Wall Street Zen cut Teleflex from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Finally, Truist Financial decreased their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $159.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.